The development of the NanoEcho imaging device completed and ready for clinical studies

The development of NanoEcho’s commercial imaging device is now completed and ready to be used on patients, in clinical studies. The formal verification has today been successfully finalised without any remarks, which is the last step in the product development. This means that the device meets the customers’ and the authorities’ requirements for medical technology […]

Health economic model for introduction of NanoEcho’s diagnostic method: basis for care decisions and pricing strategy

NanoEcho has, in collaboration with health economic experts, developed a model for health economic analysis of the introduction of NanoEcho’s method in healthcare, with the aim of investigating the potential cost-effectiveness. The health economic model shows that the introduction of NanoEcho’s diagnostic method has the potential to generate health economic gains. This analysis will form […]

NanoEcho has entered into an agreement securing the supply of nanoparticles

Today, NanoEcho has entered into a comprehensive agreement ensuring the company’s access to iron oxide-based nanoparticles, Ferrotran® (ferumoxtran), both in the short and long term. The agreement with SPL Medical represents the company’s most significant deal to date, as the choice of nanoparticles is crucial for the optimal functioning of the company’s diagnostic method. The […]

NanoEcho has been selected to participate in a business development program

NanoEcho has, as one of seven companies, been chosen to participate cost-free in the Smile Incubator and Medicon Village program “10 X Health.” The program provides expertise in business development and focuses on established Life Science companies transitioning from being a startup to becoming a scale-up. The objective of the “10 X Health” program is […]

NanoEcho strengthens its position through an agreement with Clinical Trial Consultants for the upcoming clinical phase

NanoEcho announces today that the company has entered an agreement with Clinical Trial Consultants (CTC), who will contribute with expertise, guidance, and preparatory activities for the upcoming clinical registration study. CTC is a Clinical Research Organization (CRO) and thereby specialised in planning, executing, and reporting clinical studies. The agreement means that CTC will provide expertise […]

NanoEcho submits a patent application for an advanced software algorithm for magnetomotive ultrasound

NanoEcho has officially filed a patent application with the Swedish Patent and Registration Office (PRV) for an advanced algorithm designed to enable the use of magnetomotive ultrasound in clinical examinations. The new patent aims to establish strong protection for a software algorithm that continuously calculates, filters, and visualizes clinical examination results in real-time during the […]

NanoEcho enters the formal verification phase

Today, NanoEcho enters the formal verification phase of its imaging system, in which ultrasound is used in conjunction with nanoparticles to improve rectal cancer diagnostics. This means that the integration and interaction process has been completed, an internal evaluation of the system’s performance has been made and documentation has been compiled. An independent review process […]

NanoEcho presents innovative technology at MEDICA and strengthens the MedTech network

During the past week, NanoEcho exhibited and presented at MEDICA in Düsseldorf, the world’s largest trade fair and event for the MedTech industry with 83,000 visitors. During the past week, NanoEcho participated in the MEDICA fair in Düsseldorf, the world’s largest medical industry event. As a young and innovative company, NanoEcho had the opportunity to […]

NanoEcho awarded external innovation grant for market analysis

NanoEcho has been awarded an innovation grant from Vinnova of SEK 99,000 within the scope of business development. The awarded grant is intended to finance a market analysis of potential customer segments. Vinnova’s innovation support aims to strengthen small and medium-sized companies’ innovation capacity and competitiveness. NanoEcho has been awarded a grant of SEK 99,000 […]

Pågående emission
i NanoEcho

Erbjudande om att teckna aktier i NanoEcho AB (publ) i samband med IPO
Teckningstid: 29 maj – 28 juni

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.